PMV Pharmaceuticals, Inc. Share Price
NASDAQ: PMVP | Micro CapPMV Pharmaceuticals, Inc. Stock Performance
PMV Pharmaceuticals, Inc. Share Price Today
As of 31 October 2026, PMV Pharmaceuticals, Inc.'s share price is $1.32. The stock opened at $1.33, compared to its previous close of $1.36. During today's trading session, PMV Pharmaceuticals, Inc.'s share price traded between $1.21 and $1.33, with an average price of $1.27. Over the past 52 weeks, the stock has recorded a high of $1.91 and a low of $1.02. In terms of performance, PMV Pharmaceuticals, Inc.'s share price has declined by 5.38% over the last six months and is down 5.71% on a year-on-year basis.
PMV Pharmaceuticals, Inc. Share Price Chart
PMV Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
PMV Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About PMV Pharmaceuticals, Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.
PMV Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.67 | $1.31 | -21.08% |
Sep 2026 | $1.14 | $1.66 | +32.80% |
Aug 2026 | $1.10 | $1.25 | +12.61% |
Jul 2026 | $1.30 | $1.11 | -16.54% |
Jun 2026 | $1.19 | $1.33 | +10.37% |
May 2026 | $1.38 | $1.21 | -13.62% |
Apr 2026 | $1.29 | $1.40 | +13.41% |
Mar 2026 | $1.61 | $1.23 | -27.65% |
Feb 2026 | $1.09 | $1.70 | +57.41% |
Jan 2026 | $1.29 | $1.08 | -13.60% |
Dec 2025 | $1.32 | $1.25 | -5.66% |
Nov 2025 | $1.43 | $1.32 | -5.36% |